Mostrar el registro sencillo del ítem
Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease
dc.contributor.author | Díaz-Peña R. | |
dc.contributor.author | Vidal-Castiñeira J.R. | |
dc.contributor.author | Moro-García M.A. | |
dc.contributor.author | Alonso-Arias R. | |
dc.contributor.author | Castro-Santos P. | |
dc.date.accessioned | 2020-09-02T22:16:52Z | |
dc.date.available | 2020-09-02T22:16:52Z | |
dc.date.issued | 2016 | |
dc.identifier | 10.1016/j.humimm.2015.10.020 | |
dc.identifier.citation | 77, 1, 104-109 | |
dc.identifier.issn | 01988859 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4362 | |
dc.description | We aimed to analyze the possible association of KIR/HLA-C genotypes with the susceptibility to Crohn's disease (CD) in a Spanish population. A total of 125 patients with CD and 339 healthy controls were selected for this study. KIR and HLA-C typing were developed by sequence-specific oligonucleotide probing. We found that the centromeric A/A genotype and HLA-C1 combination was significantly increased in CD patients (P < 10-3). The KIR2DL3/2DL3 genotype was significantly increased in CD patients (P < 0.0005). Moreover, we also observed a highly significant increase of KIR2DL3-HLA-C1 homozygosis in CD patients (P < 0.0005). Our results confirm the relevance of the KIR2DL2/KIR2DL3 genes and their interaction with HLA-C to CD. We show that the contribution of the KIR genes to CD susceptibility extends beyond the association with individual KIRs, with an imbalance between activating and inhibitory KIR genes seeming to influence the susceptibility to CD. © 2015 American Society for Histocompatibility and Immunogenetics. | |
dc.language.iso | en | |
dc.publisher | Elsevier Inc. | |
dc.subject | Crohn's disease | |
dc.subject | HLA | |
dc.subject | KIR | |
dc.subject | Natural killer | |
dc.subject | HLA C antigen | |
dc.subject | killer cell immunoglobulin like receptor 2DL3 | |
dc.subject | HLA C antigen | |
dc.subject | killer cell immunoglobulin like receptor 2DL2 | |
dc.subject | killer cell immunoglobulin like receptor 2DL3 | |
dc.subject | KIR2DL2 protein, human | |
dc.subject | KIR2DL3 protein, human | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | Crohn disease | |
dc.subject | gene interaction | |
dc.subject | genetic association | |
dc.subject | genetic susceptibility | |
dc.subject | genotype | |
dc.subject | homozygosity | |
dc.subject | human | |
dc.subject | immunogenetics | |
dc.subject | immunopathogenesis | |
dc.subject | major clinical study | |
dc.subject | priority journal | |
dc.subject | Spaniard | |
dc.subject | Crohn disease | |
dc.subject | gene frequency | |
dc.subject | gene linkage disequilibrium | |
dc.subject | genetic association study | |
dc.subject | genetic polymorphism | |
dc.subject | genetic predisposition | |
dc.subject | genetics | |
dc.subject | immunology | |
dc.subject | natural killer cell | |
dc.subject | Spain | |
dc.subject | Crohn Disease | |
dc.subject | Gene Frequency | |
dc.subject | Genetic Association Studies | |
dc.subject | Genetic Predisposition to Disease | |
dc.subject | Genotype | |
dc.subject | HLA-C Antigens | |
dc.subject | Humans | |
dc.subject | Killer Cells, Natural | |
dc.subject | Linkage Disequilibrium | |
dc.subject | Polymorphism, Genetic | |
dc.subject | Receptors, KIR2DL2 | |
dc.subject | Receptors, KIR2DL3 | |
dc.subject | Spain | |
dc.title | Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease | |
dc.type | Article |